Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kjetil Bjornevik

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Annals of Neurology|June 14, 2023
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal ChangesNatalia Palacios, Jeremy Wilkinson, Kjetil Bjornevik, et al.
Annals of Neurology|March 11, 2026
Distinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry-Based StudyMagne Haugland Solheim, Trond Riise, Marianna Cortese, et al.
Neurology|June 21, 2023
Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS: Post Hoc Analysis of the EMPOWER TrialKjetil Bjornevik, Marianna Cortese, Jeremy D Furtado, et al.
Expert Opinion on Drug Safety|July 31, 2018
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting SystemIppazio Cosimo Antonazzo, Emanuel Raschi, Emanuele Forcesi, et al.
Annals of Neurology|May 28, 2026
Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's DiseaseDeepika Dinesh, Xochitl C Morgan, Jordan Jensen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 21, 2023
Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based studyAkash Kapali, Anne Kjersti Daltveit, Kjell-Morten Myhr, et al.
Multiple Sclerosis and Related Disorders|January 19, 2024
In the era of antiviral trials for MS, the answer lies in the detailsNatalia Drosu, Kjetil Bjornevik, Philippe A Bilodeau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2026
Intake of Folate, Vitamin B6, and Vitamin B12 Before and After Disease Diagnosis and the Risk of Death in Individuals with Parkinson's DiseaseXinyuan Zhang, Mario H Flores-Torres, Chadwick W Christine, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting SystemIppazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2023
Subjective Cognitive Decline in Women with Features Suggestive of Prodromal Parkinson's DiseaseMario H Flores-Torres, Kjetil Bjornevik, Albert Y Hung, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Annals of Neurology|June 14, 2023
Metagenomics of the Gut Microbiome in Parkinson's Disease: Prodromal ChangesNatalia Palacios, Jeremy Wilkinson, Kjetil Bjornevik, et al.
Annals of Neurology|March 11, 2026
Distinct Prescription Patterns Emerge Years Before ALS Diagnosis: A Nationwide Registry-Based StudyMagne Haugland Solheim, Trond Riise, Marianna Cortese, et al.
Neurology|June 21, 2023
Association of Polyunsaturated Fatty Acids and Clinical Progression in Patients With ALS: Post Hoc Analysis of the EMPOWER TrialKjetil Bjornevik, Marianna Cortese, Jeremy D Furtado, et al.
Expert Opinion on Drug Safety|July 31, 2018
Multiple sclerosis as an adverse drug reaction: clues from the FDA Adverse Event Reporting SystemIppazio Cosimo Antonazzo, Emanuel Raschi, Emanuele Forcesi, et al.
Annals of Neurology|May 28, 2026
Shotgun Metagenomic Profiling of the Gut Virome in Prodromal and Confirmed Parkinson's DiseaseDeepika Dinesh, Xochitl C Morgan, Jordan Jensen, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|July 21, 2023
Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based studyAkash Kapali, Anne Kjersti Daltveit, Kjell-Morten Myhr, et al.
Multiple Sclerosis and Related Disorders|January 19, 2024
In the era of antiviral trials for MS, the answer lies in the detailsNatalia Drosu, Kjetil Bjornevik, Philippe A Bilodeau, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 12, 2026
Intake of Folate, Vitamin B6, and Vitamin B12 Before and After Disease Diagnosis and the Risk of Death in Individuals with Parkinson's DiseaseXinyuan Zhang, Mario H Flores-Torres, Chadwick W Christine, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 20, 2018
Liver injury with drugs used for multiple sclerosis: A contemporary analysis of the FDA Adverse Event Reporting SystemIppazio Cosimo Antonazzo, Elisabetta Poluzzi, Emanuele Forcesi, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|June 14, 2023
Subjective Cognitive Decline in Women with Features Suggestive of Prodromal Parkinson's DiseaseMario H Flores-Torres, Kjetil Bjornevik, Albert Y Hung, et al.
Pageof 6